XML 59 R44.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation
The following table provides information regarding our stock-based compensation:
March 31,
(In thousands)202520242023
Pre-tax share-based compensation costs charged against income$11,157 $14,010 $12,405 
Income tax benefit recognized on compensation costs$1,267 $1,190 $1,138 
Total fair value of options and RSUs vested during the period$12,185 $12,213 $10,352 
Cash received from the exercise of stock options$14,802 $18,089 $7,372 
Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises$2,273 $2,161 $1,500 
Schedule of Restricted Shares
A summary of the Company’s RSUs granted under the 2005 Plan and 2020 Plan is presented below:
 
 
 
RSUs
Shares
(in thousands)
Weighted Average
Grant Date
Fair Value
Unvested at March 31, 2022440.9 $38.45 
Granted151.0 55.03 
Incremental performance shares42.4— 
Vested (223.4)32.09 
Forfeited(1.9)49.51 
Unvested at March 31, 2023409.0 47.17 
Vested at March 31, 2023108.5 36.54 
Granted157.1 62.06 
Incremental performance shares41.4 — 
Vested (205.0)43.17 
Forfeited(10.6)52.68 
Unvested at March 31, 2024391.9 54.43 
Vested at March 31, 2024110.2 38.77 
Granted166.8 70.31 
Incremental performance shares41.1— 
Vested(192.7)47.60 
Forfeited(4.9)59.31 
Unvested at March 31, 2025402.2 63.20 
Vested at March 31, 202597.6 39.90 
Schedule of Stock Options, Valuation Assumptions
 Year Ended March 31,
 202520242023
Expected volatility
30.4% - 30.8%
30.2% - 31.6%
30.8% to 30.9%
Expected dividends
Expected term in years
6.0 to 7.0
6.0 to 7.0
6.0 to 7.0
Risk-free rate
4.5%
3.6% to 4.1%
2.8% to 2.9%
Weighted average grant date fair value of options granted$27.97$23.79$20.10
Schedule of Stock Option Activity
A summary of option activity under the 2005 Plan and 2020 Plan is as follows:
OptionsShares
(in thousands)
Weighted Average
Exercise
Price
Weighted
Average
Remaining
Contractual Term
Aggregate
Intrinsic
Value
(in thousands)
Outstanding at March 31, 20221,100.9 $40.62 
Granted197.6 54.48 
Exercised(205.2)35.93 
Forfeited(10.3)49.53 
Expired(2.0)42.63 
Outstanding at March 31, 20231,081.0 43.96 
Granted131.1 61.81 
Exercised(440.3)41.08 
Forfeited(41.0)54.15 
Expired(2.8)54.47 
Outstanding at March 31, 2024728.0 48.30 
Granted109.7 69.94 
Exercised(303.4)48.77 
Forfeited(15.6)60.87 
Outstanding at March 31, 2025518.7 52.22 6.7$17,507 
Exercisable at March 31, 2025290.3 42.92 5.4$12,499